Literature DB >> 30593367

Antibiotic susceptibility profiles of Mycoplasma hyorhinis strains isolated from swine in Hungary.

Katinka Bekő1, Orsolya Felde2, Kinga M Sulyok3, Zsuzsa Kreizinger4, Veronika Hrivnák5, Krisztián Kiss6, Imre Biksi7, Ákos Jerzsele8, Miklós Gyuranecz9.   

Abstract

Mycoplasma hyorhinis is a common pathogen of swine causing mainly polyserositis and arthritis, but it has also been implicated as a cause of pneumonia. The economic losses due to M. hyorhinis infection could be reduced by antibiotic treatment. The aim of this study was to determine minimal inhibitory concentrations (MIC) of antibiotics potentially used to combat M. hyorhinis in swine production. Thirty-eight Hungarian M. hyorhinis strains isolated between 2014 and 2017 were examined by microbroth dilution tests for fifteen antimicrobial agents. Low MIC values of tetracyclines (MIC50 0.078 μg/ml for doxycycline, ≤0.25 μg/ml for oxytetracycline) and pleuromutilins (MIC50 0.156 μg/ml for tiamulin, ≤0.039 μg/ml for valnemulin) were detected against all strains. Fluoroquinolones (MIC50 0.625 μg/ml), gentamicin (MIC50 1 μg/ml) and florfenicol (MIC50 2 μg/ml) inhibited the growth of Hungarian isolates at moderate MIC values. Most of the strains were inhibited by spectinomycin with low or moderate MIC values (MIC50 4 μg/ml) except one strain (>64 μg/ml). Numerous isolates showed decreased susceptibility to macrolides and lincomycin (MIC90 >64 for tylosin, tilmicosin, tulathromycin, gamithromycin, lincomycin, 8 μg/ml for tylvalosin). This study serves as evidence for the increasing resistance to macrolides and lincomycin in mycoplasmas, and also reports the occurrence of strains with extremely high MIC values to spectinomycin thus emphasizes the importance of the prudent use of antibiotics. Based on our results, tetracyclines and pleuromutilins are the most active compounds in vitro against the Hungarian M. hyorhinis strains.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibiotic susceptibility; MIC; Microbroth dilution; Mycoplasma hyorhinis

Mesh:

Substances:

Year:  2018        PMID: 30593367     DOI: 10.1016/j.vetmic.2018.11.027

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  10 in total

1.  Characterization of Mutations in DNA Gyrase and Topoisomerase IV in Field Strains and In Vitro Selected Quinolone-Resistant Mycoplasma hyorhinis Mutants.

Authors:  Jun Li; Yanna Wei; Jia Wang; Yao Li; Guoqing Shao; Zhixin Feng; Qiyan Xiong
Journal:  Antibiotics (Basel)       Date:  2022-04-07

2.  Anti-Mycoplasma Activity of Daptomycin and Its Use for Mycoplasma Elimination in Cell Cultures of Rickettsiae.

Authors:  Wiwit Tantibhedhyangkul; Ekkarat Wongsawat; Sutthicha Matamnan; Naharuthai Inthasin; Jintapa Sueasuay; Yupin Suputtamongkol
Journal:  Antibiotics (Basel)       Date:  2019-08-21

3.  Identification of specific B cell linear epitopes of mycoplasma hyorhinis P37 protein using monoclonal antibodies against baculovirus-expressed P37 protein.

Authors:  Hongzhen Zhu; Yanwu Wei; Liping Huang; Dan Liu; Yongxing Xie; Deli Xia; Haiqiao Bian; Li Feng; Changming Liu
Journal:  BMC Microbiol       Date:  2019-11-05       Impact factor: 3.605

4.  Antimicrobial susceptibility profiles of porcine mycoplasmas isolated from samples collected in southern Europe.

Authors:  Rubén S Rosales; Ana S Ramírez; María M Tavío; Carlos Poveda; José B Poveda
Journal:  BMC Vet Res       Date:  2020-09-03       Impact factor: 2.741

5.  Swine Conjunctivitis Associated with a Novel Mycoplasma Species Closely Related to Mycoplasma hyorhinis.

Authors:  Isabel Hennig-Pauka; Christoph Sudendey; Sven Kleinschmidt; Werner Ruppitsch; Igor Loncaric; Joachim Spergser
Journal:  Pathogens       Date:  2020-12-25

6.  A case of pericarditis caused by Mycoplasma hyorhinis in a weaned piglet.

Authors:  Martina Ustulin; Erica Rossi; Denis Vio
Journal:  Porcine Health Manag       Date:  2021-04-12

7.  DnaK Functions as a Moonlighting Protein on the Surface of Mycoplasma hyorhinis Cells.

Authors:  Yao Li; Jia Wang; Beibei Liu; Yanfei Yu; Ting Yuan; Yanna Wei; Yuan Gan; Jia Shao; Guoqing Shao; Zhixin Feng; Zhigang Tu; Qiyan Xiong
Journal:  Front Microbiol       Date:  2022-03-03       Impact factor: 5.640

8.  Antimicrobial susceptibility profiles of Mycoplasma hyorhinis strains isolated from five European countries between 2019 and 2021.

Authors:  Ulrich Klein; Dorottya Földi; Nikolett Belecz; Veronika Hrivnák; Zoltán Somogyi; Michele Gastaldelli; Marianna Merenda; Salvatore Catania; Arkadiusz Dors; Ute Siesenop; Philip Vyt; Zsuzsa Kreizinger; Wouter Depondt; Miklós Gyuranecz
Journal:  PLoS One       Date:  2022-08-11       Impact factor: 3.752

9.  Dysbiosis of Gut Microbiota and Intestinal Barrier Dysfunction in Pigs with Pulmonary Inflammation Induced by Mycoplasma hyorhinis Infection.

Authors:  Yingying Zhang; Yuan Gan; Jia Wang; Zhixin Feng; Zhaoxin Zhong; Hongduo Bao; Qiyan Xiong; Ran Wang
Journal:  mSystems       Date:  2022-06-14       Impact factor: 7.324

10.  The Monitoring of Mycoplasma gallisepticum Minimum Inhibitory Concentrations during the Last Decade (2010-2020) Seems to Reveal a Comeback of Susceptibility to Macrolides, Tiamulin, and Lincomycin.

Authors:  Marco Bottinelli; Michele Gastaldelli; Micaela Picchi; Arianna Dall'Ora; Lorena Cristovao Borges; Ana Sofía Ramírez; Andrea Matucci; Salvatore Catania
Journal:  Antibiotics (Basel)       Date:  2022-07-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.